Tumour Necrosis Factor alpha and Mucocutaneous Leishmaniasis

This publication has 32 references indexed in Scilit:

• Inhibition of TNF-induced apoptosis by NF-κB
  Trends in Cell Biology, 1998
• Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study
  Philosophical Transactions Of The Royal Society B-Biological Sciences, 1997
• Suppression of tumour necrosis factor-α expression in leprosy skin lesions during treatment for leprosy
  British Journal of Dermatology, 1997
• Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression
  AIDS, 1997
• The place of thalidomide in the treatment of inflammatory disease
  Lupus, 1996
• Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
  Nature, 1994
• An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
  The Journal of Experimental Medicine, 1993
• The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum
  The Journal of Infectious Diseases, 1993
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
  The Journal of Experimental Medicine, 1993
• Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.
  The Journal of Experimental Medicine, 1991